Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-044479
Filing Date
2021-07-01
Accepted
2021-07-01 17:14:07
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1543
2 EX-24 DOCUMENT attachment1.htm EX-24 4186
  Complete submission text file 0001209191-21-044479.txt   7134
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Issuer) CIK: 0001604477 (see all company filings)

EIN.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Coulie Bernard (Reporting) CIK: 0001808895 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39662 | Film No.: 211066936